ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 84

Physiological Autoantibodies Against the Endthelin Receptor Type-a Are Critically Involved in the Homeostasis of Immune Cells

Otávio Cabral-Marques1, Harald Heidecke2, Frank Petersen3, Xinhua Yu4 and Gabriela Riemekasten5, 1Department of Rheumatology, Vasculitis Center UKSH, University of Lübeck, Luebeck, Germany, 2CellTrend GmbH Luckenwalde, Luckenwalde, Germany, 3Research Centre Borstel, Borstel, Germany, 4Lung Centre Borstel, a Leibniz institute, Borstel, Germany, 5Department of Rheumatology, Universitatsklinikum Schleswig-Holstein, Lubeck, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoantibodies, innate immunity and migration inhibitory factor (MIF), Systemic Inflammatory

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster I: The Variable World of Intercellular Signalling

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

G protein-coupled receptors (GPCRs) are a family of integral membrane proteins mediating cell trafficking and cellular homeostasis. In the last decades, several functional autoantibodies (ab) against GPCR have been described to be involved in the pathogenesis of various diseases including systemic sclerosis. As suggested by our studies for the autoantibodies against angiotensin and endothelin receptors, anti-GPCR ab may also be present in healthy individuals. However; the role of autoantibodies in physiology is under debate.

Methods:

Antibodies against 10 different GPCR were analysed in 198 healthy donors, 249 patients with SLE, 376 patients with SSc, 47 patients with rheumatoid arthritis, and 128 patients with granulomatosis with polyangiitis (GPA) by ELISA. In patients with SSc, we also have analysed the ab levels against 31 targets including GPCR, growth factors, and signalling molecules. Possible functional interactions of the 31 autoantibody target molecules were studied by STRING, DAVID, and enriched Gene Ontology. Migration assays were performed as well as cell culture experiments stimulating PBMC with IgG from healthy donors. C56Bl/6 mice were immunized with ETAR and the cellular homeostasis was studied by flow cytometry, histology, and compared with the ab levels against anti-ETAR ab.

Results: The detection of antibodies against 10 different GPCR revealed either increased or decreased antibody levels in a disease-specific manner when compared to healthy donors. Antibodies against ETAR were increased in patients with SSc and SLE and decreased in patients with GPA. In addition to the disease-specific ab signatures, we identified SSc-specific correlations between the 31 target antibodies. Possible functional interactions of the 31 autoantibody revealed a network of GPCR, growth factors, and signalling molecules with endothelin receptor type A (ETAR) in the centre. Migration and locomotion were suggested to be the most significant functions regulated by an assumed antibody network. Accordingly, IgG from healthy donors induced both IL-8 expression in PBMC as well as, depending on the anti-ETAR ab levels, migration of neutrophils and lymphocytes, which was specifically diminished by the ETAR blocker sitaxentan. In vivo, increased anti-ETAR ab levels were associated with an altered homeostasis of innate and adaptive immune cells in different tissues.

Conclusion: As indicated for anti-ETAR antibodies, anti-GPCR antibodies reveal physiological levels in healthy donors and specific alterations in different autoimmune diseases. The antibodies are involved in the homeostasis of immune cells and could contribute to disease pathogenesis.


Disclosure: O. Cabral-Marques, None; H. Heidecke, Heideckes, 4,Riemekasten, 4; F. Petersen, None; X. Yu, None; G. Riemekasten, CellTrend, 4.

To cite this abstract in AMA style:

Cabral-Marques O, Heidecke H, Petersen F, Yu X, Riemekasten G. Physiological Autoantibodies Against the Endthelin Receptor Type-a Are Critically Involved in the Homeostasis of Immune Cells [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/physiological-autoantibodies-against-the-endthelin-receptor-type-a-are-critically-involved-in-the-homeostasis-of-immune-cells/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physiological-autoantibodies-against-the-endthelin-receptor-type-a-are-critically-involved-in-the-homeostasis-of-immune-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology